RxDoctor Payments Data

Frank Kelly

Gynecologic Oncology · Huntsville, ALNPI 1306831243

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,038, 3.7 times the $284 reported in 2019.

$4,750in general payments, 2019–2025

Across 237 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Merck$1K
  • Eisai Inc.$742
  • Seagen Inc.$496
  • Myriad Genetic Laboratories, Inc.$319
  • AstraZeneca$308
  • plus $843 from 18 others

What the payments were for

  • Food & beverage$4,65198%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,750 in reported general payments places this provider in the 70th percentile of 27 gynecologic oncology providers in Alabama.

See all gynecologic oncology providers in Alabama

Other gynecologic oncology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →